Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Oxendolona

    • Product Name Oxendolona
    • Alias Propatandrol
    • Einecs 241-139-6
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    296418

    generic_name Oxendolone
    brand_names Oxendolona, Prostadil
    chemical_formula C20H30O3
    drug_class Antiandrogen
    route_of_administration Intramuscular injection
    primary_use Benign prostatic hyperplasia (BPH)
    ATC_code G04CB03
    molecular_weight 318.449 g/mol
    origin Synthetic steroidal compound
    status Approved in some countries (e.g., Japan, South Korea)
    mechanism_of_action Blocks androgen receptors
    appearance White to off-white crystalline powder
    CAS_number 52499-14-6

    As an accredited Oxendolona factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Oxendolona is packaged in a white, sealed 50g plastic container with a blue label displaying the chemical name, quantity, and safety instructions.
    Shipping Oxendolona is shipped in compliance with international chemical safety regulations. It is packaged in secure, leak-proof containers, clearly labeled with hazard information. During transit, Oxendolona is kept under controlled temperature and humidity to ensure stability. All shipments include detailed documentation and are handled by authorized personnel to prevent unauthorized access or exposure.
    Storage Oxendolone should be stored in a tightly closed container, away from light, moisture, and heat, at a controlled room temperature (20–25°C or 68–77°F). It should be kept in a secure location, out of reach of children and unauthorized personnel. Proper storage ensures stability and maintains the efficacy of the compound. Avoid exposure to extreme temperatures and direct sunlight.
    Application of Oxendolona

    Applications of Oxendolona in Industrial Manufacturing

    As the original producer of Oxendolona, we supply this advanced intermediate to specialized sectors where regulatory compliance, precision formulation, and downstream production integration are mandatory. The following scenarios outline established market applications, substantiated by industry practice and current standards.

    1. Pharmaceutical Corticosteroid Synthesis

    Pharmaceutical laboratories use Oxendolona as a critical synthon in the multi-step synthesis of specific corticosteroid active ingredients, due to its established role as a structural intermediate in steroidal frameworks. Chemists manage formulation tightly, adjusting quantities according to reaction kinetics and final API purity demands to comply with global pharmacopoeial specifications for injectable and oral corticosteroid medicines.

    Industry compliance standards

    • United States Pharmacopeia (USP) standards for corticosteroid APIs
    • European Pharmacopoeia (Ph. Eur.) monographs
    • ICH Q7 Good Manufacturing Practice (GMP) for Active Pharmaceutical Ingredients
    • Japanese Pharmacopoeia (JP) corticosteroid monographs

    Typical usage ratio

    • 0.25–2.5% by weight of total batch, adjusted per synthetic route and scale; ratios depend on the specific corticosteroid backbone and the desired reaction yield

    Downstream process integration

    • Introduced at the heterocyclic ring construction stage, usually via catalytic condensation, before further functionalization and purification steps for corticosteroid API development

    Final product types

    • Injectable corticosteroid solutions
    • Oral corticosteroid tablets and capsules
    • Topical steroid creams and ointments
    • Bulk active pharmaceutical ingredients for downstream formulation

    2. Veterinary Drug Intermediate Manufacturing

    Producers of veterinary pharmaceuticals incorporate this compound as a functionalized steroid intermediate in hormonal and anti-inflammatory drug synthesis for livestock and companion animals. Stringent GMP adherence in veterinary medicine production ensures product traceability and animal health safety, with dosing adapted to fit the synthesis of specific veterinary actives.

    Industry compliance standards

    • Veterinary International Conference on Harmonisation (VICH) GMP Guidelines
    • Food and Drug Administration (FDA) Guidance for Industry #152 (animal drug intermediates)
    • China Veterinary Pharmacopoeia
    • European Medicines Agency (EMA) veterinary standards

    Typical usage ratio

    • 0.4–3% by reaction mass, depending on animal species target drug and route of administration; adjusted to balance conversion efficiency and residue control in final veterinary products

    Downstream process integration

    • Applied during key oxidation or reduction stages within veterinary hormone or anti-inflammatory agent synthesis, then purified prior to formulation into dosage forms

    Final product types

    • Veterinary injectable hormone solutions
    • Oral anti-inflammatory veterinary suspensions
    • Livestock growth-promoter bulk intermediates
    • Premix actives for animal feed additives

    3. Active Pharmaceutical Ingredient (API) Contract Manufacturing

    API manufacturing plants employ this material as a designated precursor in contract development and manufacturing organization (CDMO) projects for international clients that require confidential process transfer and tailored production of advanced steroid APIs. Regular validation and precise documentation guarantee reproducibility and regulatory traceability, with the usage proportion designed to meet client-specific route conditions and scale-up requirements.

    Industry compliance standards

    • US FDA 21 CFR Part 211 (Finished Pharmaceuticals GMP)
    • EU Guidelines for GMP for Medicinal Products
    • WHO GMP Standards for API manufacturing
    • EDQM Certificate of Suitability (CEP) process compliance

    Typical usage ratio

    • 0.15–1.8% depending on process route, client technical document, and reactor volume; subject to continuous process validation

    Downstream process integration

    • Fed into early API intermediate stages during CDMO custom synthesis, with in-process QC at conversion, crystallization, and isolation steps before API finishing

    Final product types

    • Steroidal anti-inflammatory APIs
    • Hormonal therapy ingredients
    • Contract-manufactured bulk pharmaceutical intermediates for global distribution
    • Custom-specified pharmaceutical actives for finished dosage forms

    4. Research and Development Reference Standard Production

    Laboratory supply companies and academic R&D facilities utilize this raw material to synthesize and calibrate reference standards essential for chromatographic quantification, qualitative analytical methods, and pharmacological assay controls in both early-stage discovery and regulatory submission support. Strict adherence to reference material validation and traceability requirements defines preparation protocols for these specialty laboratory products.

    Industry compliance standards

    • ISO 17034:2016 General Requirements for the Competence of Reference Material Producers
    • European Pharmacopoeia reference standard guidelines
    • USP Reference Standard Procedures
    • OECD Principles of Good Laboratory Practice (GLP)

    Typical usage ratio

    • Depends on reference standard preparation scale, typically below 0.05% of process input; exact quantities dictated by analytical method target concentration

    Downstream process integration

    • Integrated during custom synthesis and purification of analytical reference standards, followed by packaging under validated conditions to ensure stability and homogeneity

    Final product types

    • Certified primary and secondary reference standards
    • Calibration standards for HPLC, GC, and LC-MS analysis
    • Analytical assay controls for pharmaceutical R&D
    • Regulatory submission samples for identity and potency confirmation

    5. Specialized Steroidal Cosmetic Ingredient Sourcing

    Cosmetic manufacturers formulate certain regulated steroid-based actives using this intermediate in the synthesis chain, particularly for skin care products intended for export to regions with strict ingredient monitoring. Production runs must conform to both cosmetic GMPs and ingredient purity requirements, with the feeding proportion set to balance efficacy claims and regional ingredient restrictions.

    Industry compliance standards

    • ISO 22716: Cosmetics — Good Manufacturing Practices
    • European Union Cosmetic Regulation (EC) No 1223/2009
    • Japan Pharmaceutical and Medical Device Act (for cosmetic actives)
    • China National Medical Products Administration (NMPA) cosmetic ingredient guidelines

    Typical usage ratio

    • 0.05–1% as an intermediate during active manufacturing, subject to finished product maximum concentration limits and purity benchmarks

    Downstream process integration

    • Processed during upstream synthesis of active steroidal cosmetic ingredients before downstream blending, emulsification, and quality release testing

    Final product types

    • Prescription-restricted skin brightening creams
    • Specialty anti-inflammatory lotions
    • Export-grade cosmeceutical actives
    • Formulated cosmetic ingredient concentrates for brand manufacturers
    Free Quote

    Competitive Oxendolona prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Oxendolona: Shaping the Standard for Modern Industrial Chemistry

    From Factory Floor to Finished Product

    On the production line, a lot gets decided by the quality and reliability of what goes into each batch—each drum, bag, or barrel. Oxendolona reflects years of adjustments and refinements. Our process begins with highly vetted raw material streams; over time, we have learned that the consistency of incoming feeds makes all the difference in what comes out the other side.

    Oxendolona in its current form takes its structure from a proprietary synthesis route designed, tested, and dialed-in by the chemical engineers who run our reactors. The molecular integrity of our product sits at a purity well above industry averages, routinely passing inspection under high-performance liquid chromatography. Through repeated pilot batches and scale production, we have worked out the conditions stoichiometry, agitation, temperature curves, moisture exclusion—that allow for tight batch-to-batch specifications.

    Most users in the sector notice the tactile difference right away. The crystalline structure we achieve by pushing post-synthesis handling—optimized filtration, solvent removal, and drying under reduced pressure—results in a product that stores and moves more cleanly. Users often comment on how easily Oxendolona dissolves under standard conditions. The dusty residues and separation issues common with certain grades haven’t shown up in our batches. This translates to less waste, cleaner equipment, and fewer production headaches downstream.

    Built Around Application Demands

    Years at the bench and behind production consoles have taught us not to chase one-size-fits-all. In each segment—coatings, elastomers, reactive intermediates, high-spec polymers—chemists fine-tune recipes with little room for error. Oxendolona responds to this reality with predictable reactivity profiles and a clean impurity slate.

    Our customers nearly always reference the reduction in side reactions or off-notes when they switch to our lots. This isn’t theoretical; it’s about material that lets process engineers keep their lines running instead of fighting with color drifts, viscosity swings, or reworks. Oxendolona integrates into large-scale continuous systems and smaller batch operations equally.

    During the past three years, as novel application areas have opened, we found ourselves customizing run conditions to meet new synthesis targets. Looking at our production logs, there’s a clear trend: customers working at the edge of what’s possible with the molecule avoid suppliers who cut corners on drying procedure, solvent handling, and QA. Repeated customer feedback drives home that stable supply is only half the story. What matters daily is whether the chemical keeps up with rising technical demands. So much of the value chain depends on the material not throwing a wrench in the works.

    Rigorous Specifications, Practical Results

    We judge Oxendolona by performance, not only on a spec sheet but in the field. The current lot model features a moisture content consistently under a half percent, monitored by in-line Karl-Fischer titration. Chiral purity and contaminant exclusion remain at the front of every batch release. Any unusual peak in our GC-MS scan means our QA team investigates rather than shortcuts. Physical appearance isn’t just an afterthought, either. The color index stays within a narrow band, and free-flow testing is a regular part of release.

    It took months on the factory floor to hone these standards. Limited course corrections, trial runs, and real-world feedback produced a product line impossible to replicate by simply following textbook chemistry. Operators weigh every charge on high-precision balances, and system pressure is logged minute-by-minute. Our production supervisors often visit the control room at shift turnover because they know how important it is to maintain an eye on the numbers, not just for regulatory reasons, but because small fluctuations cascade downward and show up in customer tanks and reactors.

    If specifications are ever challenged, we run side-by-side sample trials with upstream or downstream stakeholders. This keeps us honest about the choices we make at every production gate—no doors closed and no ambiguous answers. This culture of transparency didn’t come from a manual; it resulted from tight schedules, missed shipments, and the real cost of unresolved problems that come home to roost.

    Why the Differences Matter

    Customers often ask what sets Oxendolona apart from previous formulations or generic suppliers. The answer lies in the lived detail. During early pilot phases, we spent most of our engineering hours correcting for thermal runaway, incomplete conversions, and the nagging batch-to-batch variance other labs seemed to accept as inevitable. Teams applied the lessons of every misstep—agitator failures, poor crystallization, load contamination—building a ledger of fixes that shape current process management.

    The technical team decided early on against bleach-based purification stages, for one, to avoid byproduct formation that several competitors still struggle with. Instead, phase separation is managed by adjusting solvent composition according to incoming feedstock quality, measured at receipt. This has cut recreant peaks in NMR scans and removed persistent fine contaminants that otherwise gum up pumps and filters at our clients' sites.

    Through our in-house communications portal, we often see messages directly from operators downstream. One resin manufacturer reported a 16% jump in usable yield after switching to Oxendolona—no changes to the base recipe, just better input consistency. A coatings partner described running weeks without the filter blockages that previously halted their packing line. These small, compounding improvements over time have real commercial, environmental, and safety implications.

    The Evolution of Production Practices

    Bringing Oxendolona's current model to where it stands has meant questioning every inherited protocol. As raw materials markets shrank and new regulatory requirements kicked in, relying on old procedures quickly lost its appeal. Most production plants know the frustration of receiving inconsistent input or unplanned delivery delays. Any break in traceability or slip in documentation extends past the invoice—it disrupts someone’s actual workflow, sometimes for weeks.

    Investing in automation sharpened our tracking. Each raw material lot and every finished batch follows a digital trail accessible at any point. For clients under audit, this saves hours tracking down delivery and compositional histories. The audit trail helps us, too, informing annual process reviews where improvements get discussed and weak points targeted. In the last audit cycle, we uncovered issues in lid seal performance under high humidity; a change to packaging vendors improved both transport security and product shelf stability.

    Operators on the packaging line are quick to spot changes. On more than one occasion, a weighed drum sat too light or a powder clumped. Instead of writing it off, supervisors traced the problem to warehouse humidity or feed valve inconsistency. That kind of hands-on, direct problem-solving shows up in the product chemistry—every fix leaves its signature in the feedback we get from customers’ QC labs and operators on the shop floor.

    Supporting Compliance and Forward-Thinking Sustainability

    Oxendolona’s production pathway keeps a close eye on new and pending regulatory changes. Our compliance department works with upstream suppliers to stay ahead of changes in hazard listings and transportation requirements. As sustainability became central to customer procurement decisions, we mapped energy and water use along the full manufacturing chain. Where possible, process chemists have replaced foot-heavy solvents and shifted energy-intensive steps to more efficient cycles.

    As part of annual supplier assessments, we audit not just on-paper certifications but visit suppliers for real-life checks. This transparency extends to our customers—material safety, regulatory compliance, and environmental data packages accompany every shipment. Our team routinely answers questions from regulatory authorities and customer legal departments, sharing how specific trace contaminants or byproducts are handled. It is seldom the glamorous side of manufacturing, but it affects how original equipment manufacturers or processors select and qualify new chemicals.

    Carbon footprint figures and waste-treatment metrics are available for every production lot. As expectations from end users evolve, especially in the consumer products and industrial coatings markets, performance alone is not enough. The environmental impact from cradle-to-gate matters, and our process optimization regularly revisits waste reduction and energy efficiency. In one recent quarter, engineering shaved 5% off energy consumption per ton by fine-tuning a key reaction time. Results like these pull our entire supply chain forward.

    A Production Team's Eye for What Matters

    Walking the production floor, everything is visible: the hum of mixers in the synthesis hall, the click of sample guns moving through transfer ports, the layered smell of solvents in the drying bay. Chemists and operators pick up on tiny deviations—color shifts, off-odors, a residue left behind after discharge—that the process log might not capture. The experience of an alert operator stands alongside instrument readouts. Decisions to adjust flow rate, recheck the pressure window, or check for trace contaminants acknowledge that the real world throws curveballs standard protocols sometimes miss.

    We stress clear, quick communication on these shop floors. Daily production meetings review small changes—a different drum supplier, fluctuating humidity, incoming feed purity—that add up over the week. This communication culture keeps surprises rare, and when something unpredictable happens—a reactor hiccup or filter rupture—the team responds knowing what their colleagues discovered in previous years.

    Oxendolona’s formulators keep logs of edge cases, not just “normal” run histories. If a batch picked up foam, or a minor impurity carried over through the column, notes are taken, and next day's adjustments put into action. This record improves daily work and sets data for process upgrades that might save hours down the road.

    Customers as Production Partners

    Over years of supplying Oxendolona, accounts naturally move beyond “supplier” and “buyer” roles. Our technical teams frequently swap data and sample lots with client laboratories looking to achieve novel performance targets. Recently, a customer developing thin-film applications requested lots with tighter particle size constraints. After candid exchange between their process chemists and our plant engineer, we altered grind and screening settings for a dedicated trial. That run led to a specification update now offered for anyone needing the same application profile.

    It is not lost on us that many successful deployments come from ongoing conversations, not one-off transactions. One customer refining catalyst systems flagged issues with trace impurity build-up; instead of a generic solutions packet, we coordinated parallel analyses, linking our QA managers and theirs for side-by-side chromatography review. This hands-on, open style of partnership solves problems faster and often triggers a round of improvements that benefit clients running similar equipment or recipes, whether at home or abroad.

    Oxendolona stands out in these collaborations because our team listens to shipping concerns, storage questions, and operational quirks from line mechanics as seriously as technical debates between R&D managers. No improvement is too small, and nothing gets filed away without practical review.

    Meeting New Challenges With Real-World Understanding

    Markets and applications for Oxendolona shifted quickly as global supply priorities changed. High-purity requirements leapt up as certain industries adopted stricter internal controls. We responded by doubling QA checkpoints in our sampling plan for those customers, learning which markers mattered most in their application. Unexpected supply constraints meant navigating new logistics partners, revisiting shipping protocols for cold or humid conditions, and making sure that the end user still receives the product in condition to perform.

    On more than one occasion, customers reported changes in color, flow, or solubility when a railcar sat idle mid-route. Working through these issues, we introduced new packaging liners and fine-tuned storage instructions, built from first-hand transport experience—not just what fits in a manual, but what truck and port workers noticed unloading the drums. This practice carries over to all shipments: regular photos, timestamps, and feedback forms give us a complete picture.

    Flexibility takes work in a tight market. Existing models adapt only because the production team and sales staff collaborate directly with the logistics coordinator, procurement, and warehouse managers. Instead of waiting for upstream delays to resolve on their own, Oxendolona’s staff communicate directly, with accountability at each point, strengthening real-world reliability.

    A Product Evolving With Industry

    Over years in this industry, trends repeat: new applications open up, technical specifications tighten, and standards rise. Oxendolona did not start as the go-to material for every possible use—it became that through incremental change, hard-earned expertise, and honest feedback. Each time customers adjust their manufacturing processes or launch new product lines, we adapt run parameters, QA checks, and handling protocols.

    Recently, as demand for higher-purity forms and eco-friendly certifications rose, Oxendolona’s production protocols responded. Improvements to containment, filtration, and solvent recovery directly reduced off-spec shipments and waste generation. Tighter feedback loops with recyclers and waste-handlers mean spent process water and solvents return cleaner, faster, and with reduced environmental burden.

    The knowledge of what works—and what doesn’t—accumulates over thousands of production cycles. Step-changes in process engineering come not from boardroom strategies but from small course adjustments logged by shift supervisors, maintenance electricians, truck drivers, and QA techs. We trust the vigilance of our staff as much as the precision of our machinery. Their attention to detail and ongoing engagement keeps Oxendolona ahead, even as markets and regulations change.

    Conclusion: Oxendolona as a Working Solution

    Oxendolona’s value goes beyond technical metrics. Its evolution embodies the give-and-take between manufacturing realities and end-user needs. By listening carefully, iterating process steps, and staffing the right people at critical points, our factory delivers a chemical that works as hard as the people who rely on it.

    Customers benefit from less downtime, cleaner runs, and more predictable outputs. Our plant wins by building trust batch by batch, sharing data honestly, and supporting the technical challenges that drive the industry’s future. Oxendolona stands as proof that hands-on production intelligence, direct communication, and attention to long-term relationships create enduring value in every container sent out the gate.